JNCE - Jounce Therapeutics Inc. (JNCE) CEO Rich Murray on Q2 2021 Results - Earnings Call Transcript
Jounce Therapeutics, Inc. (JNCE) Q2 2021 Earnings Conference Call August 05, 2021 08:00 A.M. ET Company Participants Mark Yore - Director of Corporate Development Richard Murray - CEO and President Elizabeth Trehu - CMO Dmitri Wiederschain - Chief Scientific Officer Kim Drapkin - CFO Conference Call Participants Ted Tenthoff - Piper Sandler Colleen Kusy - Baird Boris Peaker - Cowen Steve Seedhouse - Raymond James Swayampakula Ramakanth - H.C. Wainwright Zegbeh Jallah - ROTH Capital Partners Presentation Operator Good morning, ladies and gentlemen, and welcome to Jounce Therapeutics Second Quarter 2021 Earnings Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. As a reminder this conference is being recorded at the company’s request. I will now turn the call over to your host, Mark Yore with Jounce Therapeutics. Please go ahead. Mark Yore
For further details see:
Jounce Therapeutics, Inc. (JNCE) CEO Rich Murray on Q2 2021 Results - Earnings Call Transcript